Artelo biosciences announces publication of peer-reviewed article highlighting fabp7 as a promising novel target in cancer therapy

Provides further evidence of multiple opportunities for development of the fabp inhibitor platform in cancer & other serious conditions provides further evidence of multiple opportunities for development of the fabp inhibitor platform in cancer & other serious conditions
ARTL Ratings Summary
ARTL Quant Ranking